INS and Hypoglycemia: One of the most striking limitations of exogenously administered insulin is the risk of iatrogenic insulin-induced hypoglycemia, a risk recognized immediately after the advent of insulin therapy a century ago and which persists today despite an unrelenting effort to mitigate this risk, through frequent self-monitoring of blood glucose and informed adjustments of insulin dosage.